Wisconsin 2025 Regular Session Status: Introduced 1 R cosponsors

SB 682 — Relating to: regulating hemp-derived cannabinoid products.

Last action — Failed to pass pursuant to Senate Joint Resolution 1

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed Assembly
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Senate. Introduced December 01, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Prognosis

Stalled 22% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • Introduced

    Current position in the legislative process.

  • 10 sponsors

    1 primary, 9 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (1 R).

  • Mixed recorded votes

    1 passed, 1 failed in recorded votes so far.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

An Act to amend 94.55 (1); to create 94.55 (5) of the statutes;

Bill Text

What changed in the latest version

268 added · 81 removed

Plain-language change summary

The proposed amendments to Bill SB 682 focus on refining the testing and certification requirements for hemp-derived cannabinoid products. The changes emphasize that testing must be done by independent, accredited laboratories, ensuring that the hemp products meet specific industry standards for safety and potency. This matters because it aims to enhance consumer safety by ensuring that these products are properly evaluated before they reach the market. Additionally, the amendments clarify the procedures for submitting samples for testing, which helps maintain consistent quality in the hemp-derived product industry.

→
Previous
Latest
- 2026 LEGISLATURE LRBa0974/1 ARG:cjs SENATE AMENDMENT 1, TO SENATE BILL 682 February 2, 2026 - Offered by SenatorESTIN .
- 2026 LEGISLATURE LRB-4974/1 ARG:cjs SENATE BILL 682 December 1, 2025 - Introduced by Senator T ESTIN, cosponsored by Representatives K URTZ , SORTWELL , H YSELL, DUCHOW , KAUFERT , MURPHY , ROE , SINICKIand S TROUD .
At the locations indicated, amend the bill as follows:
Referred to Committee on Agriculture and Revenue.
A N A CT to amend 94.55 (1);
to create 94.55 (5) of the statutes;
relating to:
regulating hemp-derived cannabinoid products.
Analysis by the Legislative Reference Bureau This bill creates certain requirements and restrictions related to the sale of hemp-derived cannabinoid products and modifies the definition of hemp.
Current law defines “hemp” as “the plant Cannabis sativa L.
and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9- tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis or the maximum concentration allowed under federal law up to 1 percent, whichever is greater, as tested using post-decarboxylation or other similarly reliable methods.” Current law exempts hemp from the definitions of marijuana and tetrahydrocannabinol (THC), which are controlled substances and the possession, manufacture, or distribution of which is a criminal offense.
The bill defines “hemp-derived cannabinoid” as any cannabinoid that is extracted from hemp, including delta-6-THC, delta-8-THC, delta-9-THC, and delta- 10-THC, subject to certain exclusions.
A “hemp-derived cannabinoid product” is defined, subject to limited exceptions, as a product that contains or is labeled to contain a hemp-derived cannabinoid (HDC) and that is produced, marketed, or otherwise intended to be ingested orally, inhaled, or absorbed through the skin.
The bill specifies that the definition of hemp includes an HDC product.
The bill also modifies the definition of hemp to specify that the qualifying criteria for hemp is - 2026 Legislature - 2 - LRB-4974/1 ARG:cjs SENATE BILL 682 tested using high-performance liquid chromatography, gas chromatography-mass spectrometry, or other similarly reliable methods.
The bill prohibits a person from selling, offering to sell, or otherwise providing an HDC product to a person who has not attained 21 years of age (underage person).
The bill also prohibits an underage person from purchasing, attempting to purchase, or possessing an HDC product and from falsely representing his or her age for the purpose of obtaining an HDC product.
The bill includes a defense for an HDC product seller if the purchaser appears to be of age and provides documentation supporting his or her false representation that he or she is of age.
Under the bill, before an HDC product may be sold or offered for sale to a consumer, the product manufacturer must submit a sample of each batch of the product to an independent, accredited laboratory for testing in accordance with generally accepted industry standards, and the laboratory must certify all of the following:
1) the product contains the amount of cannabinoids stated on the label, disclosed as a percentage and as milligrams per serving and, if applicable, per container;
2) the product does not contain more than trace amounts of mold, solvents, or certain other materials;
and 3) the product is within the allowable delta-9-THC concentration for hemp.
The certifying laboratory must provide the manufacturer with a certificate of analysis of testing results (COA) for the product.
No person may sell, or offer to sell, to a consumer an HDC product unless the product is accompanied by the COA, which may be provided by means of a quick response (QR) code on the product’s label.
Under the bill, an HDC product may not be sold or offered for sale to a consumer unless the product is labeled with specified information, including 1) the name and contact information for the product’s manufacturer or brand owner;
2) the product’s serving size, servings per container, and cannabinoid profile per serving and in total for the container;
3) the product’s ingredients, including major food allergens;
4) the product’s potency, labeled as milligrams per serving, for total THC and for each HDC and the total amounts of THC and of each HDC in the product’s container;
and 5) a warning statement containing specified information.
An HDC product may not be sold or offered for sale to a consumer unless the product packaging is child-resistant and does not contain any feature likely to be appealing to children.
An HDC product must be in a tamper-evident container or packaging or have a tamper-evident seal.
Under the bill, an HDC product that is produced or marketed as a beverage 1) may not contain more than 10 milligrams of THC in a single serving, and 2) if packaged in a nonresealable container, may not be sold in a container having more than two servings.
The bill specifies that a person may manufacture and sell for export from this state a hemp-extract product that is permitted to be manufactured, packaged, prepared, transported, or held for distribution in this state even if the hemp-extract product is not permitted to be sold to a consumer in this state.
The bill also specifies that a provision of current law, which requires a referral from the Department of Agriculture, Trade and Consumer Protection before a district attorney or the Department of Justice may prosecute a hemp-related - 2026 Legislature - 3 - LRB-4974/1 ARG:cjs SENATE BILL 682 SECTION 1 violation, does not apply to enforcement of a violation of the bill’s provisions relating to HDC products.
The people of the state of Wisconsin, represented in senate and assembly, do enact as follows:
SECTION 1.
94.55 (1) of the statutes is amended to read:
94.55 (1) DEFINITION.
In this section, “hemp” means the plant Cannabis sativa L.
and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9-tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis or the maximum concentration allowed under federal law up to 1 percent, whichever is greater, as tested using post-decarboxylation high- performance liquid chromatography, gas chromatography-mass spectrometry, or other similarly reliable methods.
“Hemp” includes a hemp-derived cannabinoid product, as defined in sub.
(5) (a) 4.
Show all 192 changed rows (152 more)
Previous
Latest
“Hemp” does not include a prescription drug product that has been approved by the U.S.
food and drug administration.
SECTION 2.
94.55 (5) of the statutes is created to read:
94.55 (5) EMP -DERIVED CANNABINOID PRODUCTS .
(a) In this subsection:
Page 6, line 16:
“Batch” means a specific quantity of a hemp-derived cannabinoid product that is all of the following:
delete the material beginning with “has” and ending with line 19 and substitute “satisfies the testing and certification requirements under subds.
a.
Manufactured at the same time and using the same methods, equipment, and ingredients.
b.
Uniform and intended to meet specifications for identity, strength, purity, and composition.
- 2026 Legislature - 4 - LRB-4974/1 ARG:cjs SENATE BILL 682 S ECTION 2 c.
Manufactured, packaged, and labeled according to a single batch production record.
and 3., and the testing is conducted by an independent, accredited laboratory in accordance with generally accepted industry standards and certification made in accordance with these standards.”.
“Hemp concentrate” means the extracts or resins of hemp, including extracts or resins that are refined to increase the presence of targeted cannabinoids, but does not include refined cannabinoids or synthetic cannabinoids.
2.
Page 6, line 20:
delete “a.
The” and substitute “2.
To satisfy the requirement under subd.
1., a hemp-derived cannabinoid product manufacturer shall first submit a representative sample of each batch of the finished hemp- derived cannabinoid product for cannabinoid potency testing and laboratory certification that the”.
Page 7, line 1:
“Hemp-derived cannabinoid” means any cannabinoid, except tetrahydrocannabinol acetate or any synthetic cannabinoid, that is extracted from hemp, including a refined cannabinoid and including any of the following:
delete “b.
a.
The” and substitute “3.
Delta-6-tetrahydrocannabinol or delta-6-tetrahydrocannabinolic acid or delta-6-tetrahydrocannabivarin.
To satisfy the - 2026 Legislature - 2 - LRBARG:cjs requirement under subd.
b.
1., a hemp-derived cannabinoid product manufacturer shall first submit a representative sample of each batch of any hemp-derived cannabinoid ingredient or extract used to manufacture the product for contaminant testing and laboratory certification that any hemp-derived cannabinoid ingredient or extract used in the manufacture of the”.
Delta-8-tetrahydrocannabinol or delta-8-tetrahydrocannabinolic acid or delta-8-tetrahydrocannabivarin.
c.
Delta-9-tetrahydrocannabinol or delta-9-tetrahydrocannabinolic acid or delta-9-tetrahydrocannabivarin.
d.
Delta-10-tetrahydrocannabinol or delta-10-tetrahydrocannabinolic acid or delta-10-tetrahydrocannabivarin.
Page 7, line 4:
“Hemp-derived cannabinoid product” means a product that contains or that is labeled to contain a hemp-derived cannabinoid and that is produced, marketed, or otherwise intended to be ingested orally, inhaled, or absorbed through the skin, except that “hemp-derived cannabinoid product” does not include any of the following:
delete lines 4 to 6.
a.
A product containing hemp concentrate intended for external application to a part of the body of a human or animal and not intended to be absorbed through the skin and into the bloodstream.
- 2026 Legislature - 5 - LRB-4974/1 ARG:cjs SENATE BILL 682 SECTION 2 b.
A cannabidiol product, as defined in s.
961.01 (3r), that is governed by ss.
961.32 (2m) and 961.38 (1n) (b), and any tetrahydrocannabinol contained in a cannabidiol product that is dispensed as provided in s.
961.38 (1n) (a) or that is possessed as provided in s.
961.32 (2m) (b).
c.
A prescription drug product that has been approved by the U.S.
food and drug administration.
Page 7, line 7:
“Label” includes material attached to, printed or embossed on, or incorporated into the immediate container in which an hemp-derived cannabinoid product is sold or offered for sale.
delete “2.” and substitute “4.”.
Page 7, line 8:
“Refined cannabinoid” means a cannabinoid extracted from hemp with a chemical makeup that is changed after extraction to create a different cannabinoid or other chemical compound by applying a catalyst other than heat or light.
delete “subd.
“Refined cannabinoid” includes any tetrahydrocannabinol created from cannabidiol or hemp concentrate, except that “refined cannabinoid” does not include tetrahydrocannabinol acetate or any synthetic cannabinoid and does not include a product described in subd.
1.” and substitute “subds.
4.
2.
a.
and 3.”.
to c.
Page 7, line 10:
“Synthetic cannabinoid” means a substance with a similar chemical structure and pharmacological activity to a cannabinoid but that is not extracted or derived from hemp and is instead created or produced by chemical or biochemical synthesis.
delete “3.” and substitute “5.”.
Page 7, line 12:
“Underage person” means a person who has not attained 21 years of age.
delete “2.” and substitute “4.”.
(b) 1.
9.
No person may sell, offer to sell, or otherwise provide a hemp-derived cannabinoid product to an underage person.
Page 9, line 16:
delete “10” and substitute “12.5”.
10.
Page 9, line 21:
after that line insert:
“2g.
A hemp-derived cannabinoid product that is produced, marketed, or otherwise intended to be consumed as an edible product, other than a beverage or a tincture, may not contain more than 20 milligrams of total tetrahydrocannabinols per serving.
2r.
A hemp-derived cannabinoid product that is produced, marketed, or otherwise intended to be consumed as an edible product, other than a beverage or a tincture, may not be sold in packaging or a container having more than 40 servings.”.
11.
Page 10, line 10:
after that line insert:
- 2026 Legislature - 3 - LRBa0974/1 ARG:cjs “(i) 1.
In this paragraph, “provider” means a person who procures hemp- derived cannabinoid products for or sells, dispenses, or gives away hemp-derived cannabinoid products to an underage person in violation of par.
(b).
A person is immune from civil liability arising out of the act of procuring hemp-derived cannabinoid products for or selling, dispensing, or giving away hemp- derived cannabinoid products to another person.
An underage person may not purchase, attempt to purchase, or possess a - 2026 Legislature - 6 - LRB-4974/1 ARG:cjs SENATE BILL 682 SECTION 2 hemp-derived cannabinoid product or falsely represent his or her age for the purpose of obtaining a hemp-derived cannabinoid product.
Subdivision 2.
Proof of all of the following by a seller of hemp-derived cannabinoid products to an underage person is a defense to any prosecution for a violation of subd.
does not apply if the person procuring, selling, dispensing, or giving away hemp-derived cannabinoid products causes their consumption by force or by representing that the products do not contain any cannabinoid.
1.:
4.
Subdivision 2.
does not apply if the provider knew or should have known that the underage person was under the legal drinking age and if the hemp-derived cannabinoid products provided to the underage person were a substantial factor in causing injury to a 3rd party.
In determining whether a provider knew or should have known that the underage person was under the legal drinking age, all relevant circumstances surrounding the procuring, selling, dispensing, or giving away of the hemp-derived cannabinoid products may be considered, including any circumstance under subd.
4.
to d.
That the purchaser falsely represented that he or she had attained 21 years of age.
In addition, subd.
b.
That the appearance of the purchaser was such that an ordinary and prudent person would believe that the purchaser had attained 21 years of age.
c.
That the sale was made in good faith and in reliance on the representation and appearance of the purchaser in the belief that the purchaser had attained 21 years of age.
d.
That the underage person supported the representation under subd.
3.
a.
with documentation that he or she had attained 21 years of age.
(c) 1.
No person may sell, or offer to sell, to a consumer a hemp-derived cannabinoid product unless the product manufacturer has first submitted a representative sample of each batch of the product to an independent, accredited laboratory for testing in accordance with generally accepted industry standards and the laboratory certifies all of the following:
a.
The product contains the amount of cannabinoids stated on the label of the product, disclosed as a percentage, as milligrams per serving, and, if there is more than one serving of the product in a package or container, as total milligrams for the package or container, within a tolerance of one milligram or 10 percent, whichever is greater.
- 2026 Legislature - 7 - LRB-4974/1 ARG:cjs SENATE BILL 682 SECTION 2 b.
The product does not contain more than trace amounts of any mold, residual solvents, or other catalysts, pesticides, fertilizers, mycotoxins, or heavy metals.
c.
The product does not contain a delta-9-tetrahydrocannabinol concentration of more than 0.3 percent on a dry weight basis or the maximum concentration allowed under federal law up to 1 percent, whichever is greater.
applies if all of the following occur:
A laboratory that certifies a hemp-derived cannabinoid product as provided in subd.
1.
shall provide the manufacturer with a certificate of analysis of testing results for the product.
3.
No person may sell, or offer to sell, to a consumer a hemp-derived cannabinoid product unless the product is accompanied by the certificate of analysis of testing results specified in subd.
2., which may be provided by means of a quick response code on the product’s label.
(d) 1.
A hemp-derived cannabinoid product may not be sold or offered for sale to a consumer unless the product bears one or more labels containing all of the following information:
The underage person falsely represents that he or she has attained 21 years of age.
The name, location, phone number, and website address of the product’s manufacturer or brand owner.
The underage person supports the representation with documentation that he or she has attained 21 years of age.
The product’s batch number.
The hemp-derived cannabinoid products are provided in good faith reliance on the underage person’s representation that he or she has attained 21 years of age.
The product’s serving size and number of servings per package or container if more than one serving is included in the package or container.
- 2026 Legislature - 4 - LRBa0974/1 ARG:cjs d.
d.
The appearance of the underage person is such that an ordinary and prudent person would believe that he or she had attained 21 years of age.
The product’s cannabinoid profile per serving and in total for the container.
e.
A list of the product’s ingredients, including identification by name of any major food allergens.
- 2026 Legislature - 8 - LRB-4974/1 ARG:cjs SENATE BILL 682 S ECTION 2 f.
The product’s potency, labeled as milligrams per serving, for total tetrahydrocannabinol and for any hemp-derived cannabinoid present in excess of 1 percent of the total tetrahydrocannabinol present in the serving.
A product containing multiple servings per container or package shall also include the total amounts of tetrahydrocannabinol, and of any other hemp-derived cannabinoid present in excess of 1 percent of the total tetrahydrocannabinol, present in the package or container.
This statement of potency shall be accurate within a tolerance of one milligram or 10 percent, whichever is greater.
g.
A warning statement that is conspicuous, clearly legible, and printed in at least 6-point type on a contrasting background and that contains all of the following information:
keep out of the reach of children;
must be 21 or older to possess or consume;
may be harmful to those who are pregnant or breastfeeding;
may impair ability to drive or operate machinery;
may contain unidentified substances that are harmful or toxic;
this product is not approved by the FDA for cure, mitigation, treatment, or prevention of any disease;
and use of this product may result in a positive drug test.
h.
If the product is intended to be inhaled, the following additional warning statement, displayed in a clearly legible manner:
“WARNING:
Inhalation of cannabis smoke has been associated with lung injury.” 2.
No hemp-derived cannabinoid product may be sold or offered for sale to a consumer unless the product packaging satisfies all of the following requirements:
a.
It is child-resistant according to the packaging standards set forth in 16 CFR 1700.15, unless the product is a beverage.
b.
It does not contain any feature likely to be appealing to children, including - 2026 Legislature - 9 - LRB-4974/1 ARG:cjs SENATE BILL 682 SECTION 2 cartoon images, superhero characters, comic book characters, video game characters, television show characters, movie characters, or unicorns or other mythical creatures, or a likeness to commercially available candy, snacks, baked goods, or beverages.
3.
A hemp-derived cannabinoid product shall be placed in tamper-evident packaging or a tamper-evident container or contain a tamper-evident seal.
4.
Any information required under this paragraph on a hemp-derived cannabinoid product label may, if the immediate container holding the product is too small to contain all of the required information, instead be displayed on the product’s outer packaging and by means of a quick response code on the product label of the immediate container holding the product.
Subdivision 2.
The requirements and prohibitions in this paragraph apply in addition to those specified in sub.
does not apply to an action to impose a penalty under sub.
(3m).
(4) for a violation of par.
The provisions of sub.
(b).
(3m) (b) and (c) also apply with respect to a violation of this paragraph.
S ECTION 2m.
(e) 1.
630.20 of the statutes is created to read:
A hemp-derived cannabinoid product that is produced, marketed, or otherwise intended to be consumed as a beverage may not contain more than 10 milligrams of total tetrahydrocannabinols in a single serving.
630.20 Insurance services provided to customers engaged in hemp- derived cannabinoid product activities.
2.
An insurer who engages in the business of insurance, or an intermediary who engages in the activities described in s.
A hemp-derived cannabinoid product that is produced, marketed, or otherwise intended to be consumed as a beverage and is packaged in a nonresealable container may not be sold in a container having a capacity of more than 2 servings per container.
628.02 (1) (a), in this state does not violate any law of this state by engaging in such business or activities with respect to a customer engaged in any legal activity involving hemp-derived cannabinoid products, as defined in s.
3.
94.55 (5) (a) 4.
No person may sell in this state a hemp-derived cannabinoid product that violates this paragraph.
S ECTION 3m.
(f) Notwithstanding pars.
961.11 (5) of the statutes is amended to read:
(c) to (e), a person may manufacture and sell for - 2026 Legislature - 10 - LRB-4974/1 ARG:cjs SENATE BILL 682 SECTION 2 export from this state a hemp-extract product, whether it is a finished product or it is in the process of being manufactured, that is permitted to be manufactured for distribution, produced for distribution, packaged for distribution, processed for distribution, prepared for distribution, treated for distribution, transported for distribution, or held for distribution in this state, even if it is not permitted to be sold to a consumer in this state.
961.11 (5) The authority of the controlled substances board to control under this section does not extend to intoxicating liquors, as defined in s.
(g) Subsections (2) to (2r), (3r), and (3w) do not apply to hemp-derived cannabinoid products.
139.01 (3), to fermented malt beverages as defined in s.
(h) Section 961.32 (3) (c) does not apply to enforcement of a violation of this subsection.
125.02, to hemp-derived cannabinoid products, as defined in s.
(END )
94.55 (5) (a) 4., or to tobacco.”.
(END)
⬇ Download PDF
View plain text versions (2)

Action History

  1. Failed to pass pursuant to Senate Joint Resolution 1

  2. Available for scheduling

  3. Report passage as amended without recommendation, pursuant to Senate Rule 27 (4)(a), by Committee on Agriculture and Revenue, Ayes 4, Noes 4

  4. Report adoption of Senate Amendment 1 recommended by Committee on Agriculture and Revenue, Ayes 8, Noes 0

  5. Executive action taken

  6. Senate Amendment 1 offered by Senator Testin

  7. Representative Knodl added as a cosponsor

  8. Representative Tucker added as a cosponsor

  9. Public hearing held

  10. Representative Ortiz-Velez added as a cosponsor

  11. Representative Hong added as a cosponsor

  12. Representative Udell added as a cosponsor

  13. Senator Quinn added as a coauthor

  14. Read first time and referred to Committee on Agriculture and Revenue

  15. Introduced by Senator Testin; cosponsored by Representatives Kurtz, Sortwell, Hysell, Duchow, Kaufert, Murphy, Roe, Sinicki and Stroud

Sponsors

  • Kurtz · Cosponsor
  • Sortwell · Cosponsor
  • Hysell · Cosponsor
  • Duchow · Cosponsor
  • Kaufert · Cosponsor
  • Murphy · Cosponsor
  • Roe · Cosponsor
  • Sinicki · Cosponsor
  • Stroud · Cosponsor
  • Patrick Testin · Primary

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 9 co-sponsors · 122 not signed on

Sponsors (1)

Co-sponsors (9)

  • Kurtz
  • Sortwell
  • Hysell
  • Duchow
  • Kaufert
  • Murphy
  • Roe
  • Sinicki
  • Stroud

Not signed on (122)

122 members have not signed on to this bill.

Show all 122 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Subjects

agriculture
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 682 do?
An Act to amend 94.55 (1); to create 94.55 (5) of the statutes;
Who sponsors SB 682?
SB 682 is sponsored by Kurtz, Sortwell, Hysell, Duchow, Kaufert, Murphy, Roe, Sinicki, Stroud, and Testin, Patrick (Republican).
What is the current status of SB 682?
This bill has been introduced in the Senate. Introduced December 01, 2025. It must pass committee before a floor vote.
Where can I track SB 682?
Track SB 682 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 682

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 682

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →